Company news
Resverlogix Corp. news in 2007
Resverlogix Corp.'s news releases, calls and decks from 2007, newest first.
FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
December 10, 2007
Resverlogix Honoured with World Economic Forum Technology Pioneer Award
November 29, 2007
Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
November 5, 2007
Resverlogix is Presenting at IAS HDL Workshop
October 11, 2007
Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
October 4, 2007